[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global DNA Vaccines Market Growth 2024-2030

January 2024 | 86 pages | ID: G08BD9C10FAEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global DNA Vaccines market size was valued at US$ 4541 million in 2023. With growing demand in downstream market, the DNA Vaccines is forecast to a readjusted size of US$ 7776.4 million by 2030 with a CAGR of 8.0% during review period.

The research report highlights the growth potential of the global DNA Vaccines market. DNA Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of DNA Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the DNA Vaccines market.

The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.

Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.

Key Features:

The report on DNA Vaccines market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the DNA Vaccines market. It may include historical data, market segmentation by Type (e.g., Recombinant Protein Vaccine, Gene-Based Vaccine), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the DNA Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the DNA Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the DNA Vaccines industry. This include advancements in DNA Vaccines technology, DNA Vaccines new entrants, DNA Vaccines new investment, and other innovations that are shaping the future of DNA Vaccines.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the DNA Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for DNA Vaccines product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the DNA Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting DNA Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the DNA Vaccines market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the DNA Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the DNA Vaccines market.

Market Segmentation:

DNA Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
  • Recombinant Protein Vaccine
  • Gene-Based Vaccine
Segmentation by application
  • Human
  • Animal
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Merck
  • GSK
  • Sanofi
  • Zoties
  • Elanco
  • Boehringer-Ingelheim
  • Indian Immunologicals
  • Plumbline Life Sciences
Key Questions Addressed in this Report

What is the 10-year outlook for the global DNA Vaccines market?

What factors are driving DNA Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do DNA Vaccines market opportunities vary by end market size?

How does DNA Vaccines break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global DNA Vaccines Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for DNA Vaccines by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for DNA Vaccines by Country/Region, 2019, 2023 & 2030
2.2 DNA Vaccines Segment by Type
  2.2.1 Recombinant Protein Vaccine
  2.2.2 Gene-Based Vaccine
2.3 DNA Vaccines Sales by Type
  2.3.1 Global DNA Vaccines Sales Market Share by Type (2019-2024)
  2.3.2 Global DNA Vaccines Revenue and Market Share by Type (2019-2024)
  2.3.3 Global DNA Vaccines Sale Price by Type (2019-2024)
2.4 DNA Vaccines Segment by Application
  2.4.1 Human
  2.4.2 Animal
2.5 DNA Vaccines Sales by Application
  2.5.1 Global DNA Vaccines Sale Market Share by Application (2019-2024)
  2.5.2 Global DNA Vaccines Revenue and Market Share by Application (2019-2024)
  2.5.3 Global DNA Vaccines Sale Price by Application (2019-2024)

3 GLOBAL DNA VACCINES BY COMPANY

3.1 Global DNA Vaccines Breakdown Data by Company
  3.1.1 Global DNA Vaccines Annual Sales by Company (2019-2024)
  3.1.2 Global DNA Vaccines Sales Market Share by Company (2019-2024)
3.2 Global DNA Vaccines Annual Revenue by Company (2019-2024)
  3.2.1 Global DNA Vaccines Revenue by Company (2019-2024)
  3.2.2 Global DNA Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global DNA Vaccines Sale Price by Company
3.4 Key Manufacturers DNA Vaccines Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers DNA Vaccines Product Location Distribution
  3.4.2 Players DNA Vaccines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR DNA VACCINES BY GEOGRAPHIC REGION

4.1 World Historic DNA Vaccines Market Size by Geographic Region (2019-2024)
  4.1.1 Global DNA Vaccines Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global DNA Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic DNA Vaccines Market Size by Country/Region (2019-2024)
  4.2.1 Global DNA Vaccines Annual Sales by Country/Region (2019-2024)
  4.2.2 Global DNA Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas DNA Vaccines Sales Growth
4.4 APAC DNA Vaccines Sales Growth
4.5 Europe DNA Vaccines Sales Growth
4.6 Middle East & Africa DNA Vaccines Sales Growth

5 AMERICAS

5.1 Americas DNA Vaccines Sales by Country
  5.1.1 Americas DNA Vaccines Sales by Country (2019-2024)
  5.1.2 Americas DNA Vaccines Revenue by Country (2019-2024)
5.2 Americas DNA Vaccines Sales by Type
5.3 Americas DNA Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC DNA Vaccines Sales by Region
  6.1.1 APAC DNA Vaccines Sales by Region (2019-2024)
  6.1.2 APAC DNA Vaccines Revenue by Region (2019-2024)
6.2 APAC DNA Vaccines Sales by Type
6.3 APAC DNA Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe DNA Vaccines by Country
  7.1.1 Europe DNA Vaccines Sales by Country (2019-2024)
  7.1.2 Europe DNA Vaccines Revenue by Country (2019-2024)
7.2 Europe DNA Vaccines Sales by Type
7.3 Europe DNA Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa DNA Vaccines by Country
  8.1.1 Middle East & Africa DNA Vaccines Sales by Country (2019-2024)
  8.1.2 Middle East & Africa DNA Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa DNA Vaccines Sales by Type
8.3 Middle East & Africa DNA Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of DNA Vaccines
10.3 Manufacturing Process Analysis of DNA Vaccines
10.4 Industry Chain Structure of DNA Vaccines

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 DNA Vaccines Distributors
11.3 DNA Vaccines Customer

12 WORLD FORECAST REVIEW FOR DNA VACCINES BY GEOGRAPHIC REGION

12.1 Global DNA Vaccines Market Size Forecast by Region
  12.1.1 Global DNA Vaccines Forecast by Region (2025-2030)
  12.1.2 Global DNA Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global DNA Vaccines Forecast by Type
12.7 Global DNA Vaccines Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck DNA Vaccines Product Portfolios and Specifications
  13.1.3 Merck DNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments
13.2 GSK
  13.2.1 GSK Company Information
  13.2.2 GSK DNA Vaccines Product Portfolios and Specifications
  13.2.3 GSK DNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 GSK Main Business Overview
  13.2.5 GSK Latest Developments
13.3 Sanofi
  13.3.1 Sanofi Company Information
  13.3.2 Sanofi DNA Vaccines Product Portfolios and Specifications
  13.3.3 Sanofi DNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 Sanofi Main Business Overview
  13.3.5 Sanofi Latest Developments
13.4 Zoties
  13.4.1 Zoties Company Information
  13.4.2 Zoties DNA Vaccines Product Portfolios and Specifications
  13.4.3 Zoties DNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Zoties Main Business Overview
  13.4.5 Zoties Latest Developments
13.5 Elanco
  13.5.1 Elanco Company Information
  13.5.2 Elanco DNA Vaccines Product Portfolios and Specifications
  13.5.3 Elanco DNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Elanco Main Business Overview
  13.5.5 Elanco Latest Developments
13.6 Boehringer-Ingelheim
  13.6.1 Boehringer-Ingelheim Company Information
  13.6.2 Boehringer-Ingelheim DNA Vaccines Product Portfolios and Specifications
  13.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Boehringer-Ingelheim Main Business Overview
  13.6.5 Boehringer-Ingelheim Latest Developments
13.7 Indian Immunologicals
  13.7.1 Indian Immunologicals Company Information
  13.7.2 Indian Immunologicals DNA Vaccines Product Portfolios and Specifications
  13.7.3 Indian Immunologicals DNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Indian Immunologicals Main Business Overview
  13.7.5 Indian Immunologicals Latest Developments
13.8 Plumbline Life Sciences
  13.8.1 Plumbline Life Sciences Company Information
  13.8.2 Plumbline Life Sciences DNA Vaccines Product Portfolios and Specifications
  13.8.3 Plumbline Life Sciences DNA Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Plumbline Life Sciences Main Business Overview
  13.8.5 Plumbline Life Sciences Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. DNA Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. DNA Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Recombinant Protein Vaccine
Table 4. Major Players of Gene-Based Vaccine
Table 5. Global DNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 6. Global DNA Vaccines Sales Market Share by Type (2019-2024)
Table 7. Global DNA Vaccines Revenue by Type (2019-2024) & ($ million)
Table 8. Global DNA Vaccines Revenue Market Share by Type (2019-2024)
Table 9. Global DNA Vaccines Sale Price by Type (2019-2024) & (USD/Unit)
Table 10. Global DNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 11. Global DNA Vaccines Sales Market Share by Application (2019-2024)
Table 12. Global DNA Vaccines Revenue by Application (2019-2024)
Table 13. Global DNA Vaccines Revenue Market Share by Application (2019-2024)
Table 14. Global DNA Vaccines Sale Price by Application (2019-2024) & (USD/Unit)
Table 15. Global DNA Vaccines Sales by Company (2019-2024) & (K Units)
Table 16. Global DNA Vaccines Sales Market Share by Company (2019-2024)
Table 17. Global DNA Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 18. Global DNA Vaccines Revenue Market Share by Company (2019-2024)
Table 19. Global DNA Vaccines Sale Price by Company (2019-2024) & (USD/Unit)
Table 20. Key Manufacturers DNA Vaccines Producing Area Distribution and Sales Area
Table 21. Players DNA Vaccines Products Offered
Table 22. DNA Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global DNA Vaccines Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global DNA Vaccines Sales Market Share Geographic Region (2019-2024)
Table 27. Global DNA Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global DNA Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global DNA Vaccines Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global DNA Vaccines Sales Market Share by Country/Region (2019-2024)
Table 31. Global DNA Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global DNA Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas DNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 34. Americas DNA Vaccines Sales Market Share by Country (2019-2024)
Table 35. Americas DNA Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas DNA Vaccines Revenue Market Share by Country (2019-2024)
Table 37. Americas DNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 38. Americas DNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 39. APAC DNA Vaccines Sales by Region (2019-2024) & (K Units)
Table 40. APAC DNA Vaccines Sales Market Share by Region (2019-2024)
Table 41. APAC DNA Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC DNA Vaccines Revenue Market Share by Region (2019-2024)
Table 43. APAC DNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 44. APAC DNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 45. Europe DNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 46. Europe DNA Vaccines Sales Market Share by Country (2019-2024)
Table 47. Europe DNA Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe DNA Vaccines Revenue Market Share by Country (2019-2024)
Table 49. Europe DNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 50. Europe DNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa DNA Vaccines Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa DNA Vaccines Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa DNA Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa DNA Vaccines Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa DNA Vaccines Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa DNA Vaccines Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of DNA Vaccines
Table 58. Key Market Challenges & Risks of DNA Vaccines
Table 59. Key Industry Trends of DNA Vaccines
Table 60. DNA Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. DNA Vaccines Distributors List
Table 63. DNA Vaccines Customer List
Table 64. Global DNA Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global DNA Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas DNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas DNA Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC DNA Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC DNA Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe DNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe DNA Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa DNA Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa DNA Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global DNA Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global DNA Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global DNA Vaccines Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global DNA Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Merck Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck DNA Vaccines Product Portfolios and Specifications
Table 80. Merck DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. GSK Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK DNA Vaccines Product Portfolios and Specifications
Table 85. GSK DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. Sanofi Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanofi DNA Vaccines Product Portfolios and Specifications
Table 90. Sanofi DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments
Table 93. Zoties Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Zoties DNA Vaccines Product Portfolios and Specifications
Table 95. Zoties DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Zoties Main Business
Table 97. Zoties Latest Developments
Table 98. Elanco Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Elanco DNA Vaccines Product Portfolios and Specifications
Table 100. Elanco DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Elanco Main Business
Table 102. Elanco Latest Developments
Table 103. Boehringer-Ingelheim Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Boehringer-Ingelheim DNA Vaccines Product Portfolios and Specifications
Table 105. Boehringer-Ingelheim DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Boehringer-Ingelheim Main Business
Table 107. Boehringer-Ingelheim Latest Developments
Table 108. Indian Immunologicals Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Indian Immunologicals DNA Vaccines Product Portfolios and Specifications
Table 110. Indian Immunologicals DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Indian Immunologicals Main Business
Table 112. Indian Immunologicals Latest Developments
Table 113. Plumbline Life Sciences Basic Information, DNA Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Plumbline Life Sciences DNA Vaccines Product Portfolios and Specifications
Table 115. Plumbline Life Sciences DNA Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Plumbline Life Sciences Main Business
Table 117. Plumbline Life Sciences Latest Developments

LIST OF FIGURES

Figure 1. Picture of DNA Vaccines
Figure 2. DNA Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global DNA Vaccines Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global DNA Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. DNA Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Recombinant Protein Vaccine
Figure 10. Product Picture of Gene-Based Vaccine
Figure 11. Global DNA Vaccines Sales Market Share by Type in 2023
Figure 12. Global DNA Vaccines Revenue Market Share by Type (2019-2024)
Figure 13. DNA Vaccines Consumed in Human
Figure 14. Global DNA Vaccines Market: Human (2019-2024) & (K Units)
Figure 15. DNA Vaccines Consumed in Animal
Figure 16. Global DNA Vaccines Market: Animal (2019-2024) & (K Units)
Figure 17. Global DNA Vaccines Sales Market Share by Application (2023)
Figure 18. Global DNA Vaccines Revenue Market Share by Application in 2023
Figure 19. DNA Vaccines Sales Market by Company in 2023 (K Units)
Figure 20. Global DNA Vaccines Sales Market Share by Company in 2023
Figure 21. DNA Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 22. Global DNA Vaccines Revenue Market Share by Company in 2023
Figure 23. Global DNA Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global DNA Vaccines Revenue Market Share by Geographic Region in 2023
Figure 25. Americas DNA Vaccines Sales 2019-2024 (K Units)
Figure 26. Americas DNA Vaccines Revenue 2019-2024 ($ Millions)
Figure 27. APAC DNA Vaccines Sales 2019-2024 (K Units)
Figure 28. APAC DNA Vaccines Revenue 2019-2024 ($ Millions)
Figure 29. Europe DNA Vaccines Sales 2019-2024 (K Units)
Figure 30. Europe DNA Vaccines Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa DNA Vaccines Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa DNA Vaccines Revenue 2019-2024 ($ Millions)
Figure 33. Americas DNA Vaccines Sales Market Share by Country in 2023
Figure 34. Americas DNA Vaccines Revenue Market Share by Country in 2023
Figure 35. Americas DNA Vaccines Sales Market Share by Type (2019-2024)
Figure 36. Americas DNA Vaccines Sales Market Share by Application (2019-2024)
Figure 37. United States DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC DNA Vaccines Sales Market Share by Region in 2023
Figure 42. APAC DNA Vaccines Revenue Market Share by Regions in 2023
Figure 43. APAC DNA Vaccines Sales Market Share by Type (2019-2024)
Figure 44. APAC DNA Vaccines Sales Market Share by Application (2019-2024)
Figure 45. China DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 49. India DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe DNA Vaccines Sales Market Share by Country in 2023
Figure 53. Europe DNA Vaccines Revenue Market Share by Country in 2023
Figure 54. Europe DNA Vaccines Sales Market Share by Type (2019-2024)
Figure 55. Europe DNA Vaccines Sales Market Share by Application (2019-2024)
Figure 56. Germany DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 57. France DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa DNA Vaccines Sales Market Share by Country in 2023
Figure 62. Middle East & Africa DNA Vaccines Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa DNA Vaccines Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa DNA Vaccines Sales Market Share by Application (2019-2024)
Figure 65. Egypt DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country DNA Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of DNA Vaccines in 2023
Figure 71. Manufacturing Process Analysis of DNA Vaccines
Figure 72. Industry Chain Structure of DNA Vaccines
Figure 73. Channels of Distribution
Figure 74. Global DNA Vaccines Sales Market Forecast by Region (2025-2030)
Figure 75. Global DNA Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global DNA Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global DNA Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global DNA Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global DNA Vaccines Revenue Market Share Forecast by Application (2025-2030)


More Publications